Horner Syndrome, from Suspicion to Diagnosis Confirmation and Treatment
SPMI CASE REPORTS · 11.07.2023
DOI: 10.60591/crspmi.99 ↗Kurz gefasst
Fachartikel in der Zeitschrift SPMI CASE REPORTS, erschienen am 11.07.2023. Verfasst von Costa und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Horner syndrome (HS) is characterized by ptosis, miosis and anhidrosis, due to an interruption of the oculosympathetic pathway along the cephalic, ocular or neck segments. This clinical case reports a 53-year-old man with a one week history of frontal headache, right ptosis and anisocoria. Cerebral and supra-aortic vessels angio-computed tomography was performed, excluding an acute ischemic or hemorrhagic event and carotid dissection. At the third apraclonidine test attempt, 8 days after admission, HS was confirmed. Then a cranioencephalic angio-magnetic resonance imaging was performed, revealing carotid dissection. The patient was proposed to initiate antiplatelet and antilipidemic therapy. After three months, he presented extracranial carotid dissection resolution. In this case, we emphasize the role of the apraclonidine test in this neurologic syndrome approach, and a conservative therapeutic approach allowed not only case resolution, but also iatrogenic mitigation.
Schlagwörter
Zitieren
APA
Costa, Magda, Sá, C. D., Sá, A. C. D., Pires, Pires, J., Gonçalves, Gonçalves, F., & Cotter, J. (2023). Horner Syndrome, from Suspicion to Diagnosis Confirmation and Treatment. SPMI CASE REPORTS. https://doi.org/10.60591/crspmi.99
Vancouver
Costa, Magda, Sá CD, Sá ACD, Pires, Pires J, et al. Horner Syndrome, from Suspicion to Diagnosis Confirmation and Treatment. SPMI CASE REPORTS. 2023. doi:10.60591/crspmi.99
BibTeX
@article{Costa2023,
author = {Costa and Magda and Sá, Correia De and Sá, Ana Correia De and Pires and Pires, Joana and Gonçalves and Gonçalves, Filipe and Cotter, Jorge},
title = {Horner Syndrome, from Suspicion to Diagnosis Confirmation and Treatment},
journal = {SPMI CASE REPORTS},
year = {2023},
doi = {10.60591/crspmi.99}
}
EUVIMED